Dr. Kuldip Dave joined The ALS Association in 2019 and oversees the research program. In this role, he develops and implements the broader research vision by setting annual priorities and department goals including research funding strategy, research programs, and strategic initiatives. He engages with various stakeholders including key opinion leaders from academia, government, industry, and other nonprofit organizations.

Dr. Dave received his bachelor’s degree in biology from Rutgers University in New Brunswick, NJ. He received his Ph.D. degree in Pharmacology and Physiology from Drexel University College of Medicine in Philadelphia, Pa. He went on to do postdoctoral fellowship at a small biotechnology company in Pennsylvania where he was first exposed to the drug development process. He went to work for the pharmaceutical company Wyeth for two years before joining The Michael J. Fox Foundation for Parkinson’s research. At MJFF, he oversaw a $30M portfolio and led two priority therapeutic areas. After nine years at MJFF, he joined The ALS Association as the head of the Research program.